S. Hafizi et al., Inhibition of human cardiac fibroblast mitogenesis by blockade of mitogen-activated protein kinase and phosphatidylinositol 3-kinase, CLIN EXP PH, 26(7), 1999, pp. 511-513
Citations number
20
Categorie Soggetti
Pharmacology & Toxicology
Journal title
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
1. Interstitial fibroblast proliferation is an elemental feature in the dev
elopment of cardiac fibrosis. The effects of inhibitors of the intracellula
r signalling proteins, MEK, a kinase involved in the mitogen-activated prot
ein kinase (MAP) pathway and phosphatidylinositol 3-kinase (PI3-K), were te
sted on growth of cultured human cardiac fibroblasts,
2. Cardiac fibroblasts were isolated from transplant recipient myocardium a
nd made quiescent by serum deprivation for;48 h, Cells were incubated for 2
4 h with the inhibitors PD 098059 (0.3-30 mu mol/L) and LY294002 (1-25 mu m
ol/L) in the presence and absence of platelet-derived growth factor-AB (PDG
F-AB, 10 ng/mL), DNA synthesis was measured by [H-3]-thymidine incorporatio
n assay (20-24 h),
3. Both compounds markedly inhibited both basal and PDGF-stimulated increas
es in DNA synthesis in a concentration-dependent manner. Cardiac fibroblast
DNA synthesis was reduced to near control levels by PD 098059, while it wa
s inhibited completely by LY294002.
4. These results implicate the importance of MAPK and PI3-K activation in t
he signal transduction pathways necessary for cardiac fibroblast replicatio
n.